<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04423276</url>
  </required_header>
  <id_info>
    <org_study_id>DNPQ20200523</org_study_id>
    <nct_id>NCT04423276</nct_id>
  </id_info>
  <brief_title>Efficiency of Donepezil in Elderly Patients for Prevention of POCD Dysfunction</brief_title>
  <official_title>Efficiency of Donepezil in Elderly Patients Undergoing Orthopedic Surgery Due to Underlying Postoperative Cognitive Dysfunction, a Multicenter Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tenth People's Hospital of Tongji Univeristy</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative cognitive dysfunction (POCD) occurs mainly in aged patients. POCD may increase
      the mortality and morbidity. However, the mechanism of POCD is not clear yet and no effective
      therapy method was proved. According to our previous study, the central cholinergic system
      impaired by the anesthesia and surgery play a very important role in the POCD and donepezil
      an acetylcholinesterase inhibitor can prevent the POCD after isoflurane anesthesia in aged
      mice. Donepezil is a commercial medicine used for the Alzheimer Disease, which is tolerable
      and has minimal adverse events. In present study a multi-center randomized case control study
      was conducted and we hypothesized that donepezil attenuate the POCD.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">June 14, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of POCD after the surgery.</measure>
    <time_frame>up to 7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The incidence of postoperative delirium after surgery.</measure>
    <time_frame>1 to 7 days after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>POCD incidence one month, six months and one year after surgery.</measure>
    <time_frame>one month, six months and one year after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Total Knee Arthroplasty</condition>
  <condition>Fracture of Head of Femur Articular Displaced</condition>
  <condition>Protrusion of Intervertebral Disc</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Donepezil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Donepezil</intervention_name>
    <description>Donepezil a cholinesterase inhibitor, 5mg(1 pill)/ day for 7 days Po, was administrated from the day before surgery.</description>
    <arm_group_label>Donepezil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo, 1 pill/ day for 7 days Po, was administrated from the day before surgery.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Elder than 60 years old

          2. Speak Chinese Mandarin

          3. Scheduled to undergo hip or knee replacement surgery and lumbar spine surgery

          4. The operation time is more than 2 hours.

        4) Signed the inform consent 5) American Society of Anesthesiologists (ASA) classification
        I-III

        Exclusion Criteria:

          1. Existing cerebral disease, or have a history of neurological and psychiatric diseases
             including Alzheimer Disease, stroke, epilepsy and psychosis

          2. Existing cognitive impairment as evidenced by Mini-Mental State Examination scores
             below 24

          3. Several audition or vision disorder

          4. Patients with tumors or infections

          5. Unwillingness to comply with the protocol or procedures

          6. Can not communicate normally in Mandarin Chinese

          7. Existing bradycardiac arrhythmia (Heart rate &lt;60 bpm for any reasons)

          8. Existing gastrointestinal ulcer

          9. Existing urinary incontinence

         10. Existing asthma or chronic obstructive pulmonary disease

         11. Postoperative admission to ICU

         12. Allergic to donepezil
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology Renji Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, M.D., Ph.D.</last_name>
    <phone>+8618616514088</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diansan Su</last_name>
      <phone>+862168383702</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 6, 2020</study_first_submitted>
  <study_first_submitted_qc>June 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>June 14, 2020</last_update_submitted>
  <last_update_submitted_qc>June 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Donepezil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

